APOBEC3B mutagenesis in cancer
- PMID: 23985681
- PMCID: PMC3965181
- DOI: 10.1038/ng.2736
APOBEC3B mutagenesis in cancer
Abstract
Recent evidence has implicated APOBEC3B as a source of mutations in cervical, bladder, lung, head and neck, and breast cancers. APOBEC enzymes normally function in innate immune responses, including those that target retroviruses, suggesting links between mutagenesis, immunity and viral infection in the process of cancer development.
Figures
Comment on
-
Evidence for APOBEC3B mutagenesis in multiple human cancers.Nat Genet. 2013 Sep;45(9):977-83. doi: 10.1038/ng.2701. Epub 2013 Jul 14. Nat Genet. 2013. PMID: 23852168 Free PMC article.
-
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.Nat Genet. 2013 Sep;45(9):970-6. doi: 10.1038/ng.2702. Epub 2013 Jul 14. Nat Genet. 2013. PMID: 23852170 Free PMC article.
References
-
- Harris RS, Liddament MT. Nat. Rev. Immunol. 2004;4:868–877. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
